Sri Handayani
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Sri Handayani has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Fitri Octaviana
Neurology Jakarta Special Capital Region of Jakarta 10430 Universitas Indonesia Fakultas Kedokteran
3 shared publications - Radiyati Umi Partan
Universitas Sriwijaya
3 shared publications - Zen Hafy
Universitas Sriwijaya
2 shared publications - Astri Budikayanti
Neurology Department, University of Indonesia, Depok, Indonesia
1 shared publication Desia Banjarani
Universitas Sriwijaya
1 shared publication- Dessy Agustini
Department of Medical Profession, Faculty of Medicine Sriwijaya University Palembang South Sumatra Indonesia
1 shared publication
Latest Publications
- Open Access
- 31 March 2026
- Published by International Society for Neuroregulation and Research (ISNR) in NeuroRegulation
- Vol. 13 (1)
The Effectiveness of Neurofeedback Training on Cognitive Function Improvement and Quantitative Electroencephalography Features in Poststroke Cognitive Impairment
Background. Poststroke cognitive impairment (PSCI) involves cognitive deficits emerging within 3 months after stroke. Quantitative EEG (qEEG) in PSCI typically shows changes in relative power, delta-alpha ratio, and peak alpha frequency. Neurofeedback training (NFT) is a promising intervention to improve cognitive function and qEEG patterns, though findings remain inconsistent. Nonetheless, even brief NFT interventions may yield meaningful benefits. Methods. This study assessed the effectiveness of five individualized qEEG-guided NFT sessions (30 min each) in 24 PSCI patients, focusing on changes in MoCA-INA scores and qEEG parameters. Results. NFT significantly improved MoCA-INA scores (Z = −4.106, p < .001, effect size = 0.839), particularly in visuospatial/executive and delayed recall domains, with sustained effects 1 month later. QEEG analysis revealed increased temporal alpha (t = −1.875, p = .037, effect size = 0.23) and parietal beta relative power (t = −1.827, p = .040, effect size = 0.11). Greater cognitive gains were observed in patients aged ≤60 years. Conclusion. These findings support the clinical utility of short-term, qEEG-guided NFT in improving cognitive outcomes and modulating neural activity in PSCI patients. The sustained benefits observed suggest potential for long-term therapeutic impact.
- 31 March 2026
- Published by International Society for Neuroregulation and Research (ISNR) in NeuroRegulation
- Vol. 13 (1)
Open AccessThe Effectiveness of Neurofeedback Training on Cognitive Function Improvement and Quantitative Electroencephalography Features in Poststroke Cognitive Impairment
Background. Poststroke cognitive impairment (PSCI) involves cognitive deficits emerging within 3 months after stroke. Quantitative EEG (qEEG) in PSCI typically shows changes in relative power, delta-alpha ratio, and peak alpha frequency. Neurofeedback training (NFT) is a promising intervention to improve cognitive function and qEEG patterns, though findings remain inconsistent. Nonetheless, even brief NFT interventions may yield meaningful benefits. Methods. This study assessed the effectiveness of five individualized qEEG-guided NFT sessions (30 min each) in 24 PSCI patients, focusing on changes in MoCA-INA scores and qEEG parameters. Results. NFT significantly improved MoCA-INA scores (Z = −4.106, p < .001, effect size = 0.839), particularly in visuospatial/executive and delayed recall domains, with sustained effects 1 month later. QEEG analysis revealed increased temporal alpha (t = −1.875, p = .037, effect size = 0.23) and parietal beta relative power (t = −1.827, p = .040, effect size = 0.11). Greater cognitive gains were observed in patients aged ≤60 years. Conclusion. These findings support the clinical utility of short-term, qEEG-guided NFT in improving cognitive outcomes and modulating neural activity in PSCI patients. The sustained benefits observed suggest potential for long-term therapeutic impact.
- Open Access
- 27 February 2026
- Published by Medical Association of Zenica-Doboj in Medicinski Glasnik
- Vol. 23 (1) , 111-116
Effect of vitamin D supplementation on metabolic syndrome and atherosclerosis biomarkers in epilepsy: a randomized controlled trial
Aim To analyze the effect of vitamin D administration on serum 25(OH)D levels and biomarkers of metabolic syndrome and atherosclerosis (homeostatic model assessment of insulin resistance [HOMA-IR], adiponectin, homocysteine, and high sensitivity C-reactive protein [hs-CRP]) in epilepsy patients receiving enzymatic antiseizure medications (ASMs). Methods This double-blind, randomized, placebo-controlled trial randomized 40 adult epilepsy patients treated with enzymatic ASMs to receive vitamin D3 (2,000 IU/day) or placebo for 12 weeks. The primary outcome was the change in serum 25-hydroxyvitamin D (25[OH]D) levels. Secondary outcomes included changes in HOMA-IR, adiponectin, homocysteine, and hs-CRP. Data were analyzed using a per-protocol approach. Results Thirty-four patients completed the study. Vitamin D supplementation yielded a significantly greater increase in serum 25(OH)D (10.67 ± 8.16 vs. –1.29 ± 3.96 ng/mL; p < 0.001) and adiponectin (1.38 ± 3.05 vs. 0.34 ± 1.89 µg/mL; p = 0.045), as well as a significantly greater reduction in hs-CRP (–6.74 ± 14.65 vs. 1.81 ± 7.75 mg/L; p = 0.041) compared with placebo. Conversely, no significant differences were observed between groups regarding the changes in HOMA-IR (–0.24 ± 3.71 vs. –0.14 ± 3.38; p = 0.940) or homocysteine (7.90 ± 1.79 vs. 8.15 ± 2.70 µmol/L; p = 0.290). Conclusion Vitamin D supplementation (2,000 IU/day) effectively restores 25(OH)D levels and improves adiponectin and hs-CRP in epilepsy patients on enzymatic ASMs, suggesting a potential benefit for cardiovascular risk reduction. However, vitamin D alone did not prevent the rise in homocysteine, likely due to the concurrent cessation of B-vitamin supplementation.
- 27 February 2026
- Published by Medical Association of Zenica-Doboj in Medicinski Glasnik
- Vol. 23 (1) , 111-116
Open AccessEffect of vitamin D supplementation on metabolic syndrome and atherosclerosis biomarkers in epilepsy: a randomized controlled trial
Aim To analyze the effect of vitamin D administration on serum 25(OH)D levels and biomarkers of metabolic syndrome and atherosclerosis (homeostatic model assessment of insulin resistance [HOMA-IR], adiponectin, homocysteine, and high sensitivity C-reactive protein [hs-CRP]) in epilepsy patients receiving enzymatic antiseizure medications (ASMs). Methods This double-blind, randomized, placebo-controlled trial randomized 40 adult epilepsy patients treated with enzymatic ASMs to receive vitamin D3 (2,000 IU/day) or placebo for 12 weeks. The primary outcome was the change in serum 25-hydroxyvitamin D (25[OH]D) levels. Secondary outcomes included changes in HOMA-IR, adiponectin, homocysteine, and hs-CRP. Data were analyzed using a per-protocol approach. Results Thirty-four patients completed the study. Vitamin D supplementation yielded a significantly greater increase in serum 25(OH)D (10.67 ± 8.16 vs. –1.29 ± 3.96 ng/mL; p < 0.001) and adiponectin (1.38 ± 3.05 vs. 0.34 ± 1.89 µg/mL; p = 0.045), as well as a significantly greater reduction in hs-CRP (–6.74 ± 14.65 vs. 1.81 ± 7.75 mg/L; p = 0.041) compared with placebo. Conversely, no significant differences were observed between groups regarding the changes in HOMA-IR (–0.24 ± 3.71 vs. –0.14 ± 3.38; p = 0.940) or homocysteine (7.90 ± 1.79 vs. 8.15 ± 2.70 µmol/L; p = 0.290). Conclusion Vitamin D supplementation (2,000 IU/day) effectively restores 25(OH)D levels and improves adiponectin and hs-CRP in epilepsy patients on enzymatic ASMs, suggesting a potential benefit for cardiovascular risk reduction. However, vitamin D alone did not prevent the rise in homocysteine, likely due to the concurrent cessation of B-vitamin supplementation.
- Open Access
- 26 June 2025
- Published by Brawijaya University in MNJ (Malang Neurology Journal)
- Vol. 11 (2) , 164-169
THE RELATIONSHIP OF THE CHARACTERISTICS OF ANTI-EPILEPSY DRUGS WITH THE C OGNITIVE FUNCTION OF EPILEPSY PATIENTS
Background: One of the side effects of the use of antiepileptic drugs (AEDs) is cognitive disorder. Several studies show a relationship between the type of AEDs and cognitive disturbance in people with epilepsy. Dose-dependent side effects of AEDs have also been reported in prior research. However, there are results from different studies on different populations. Objective: This research aims to evaluate the relationship between AEDs characteristics and the cognitive function of epilepsy patients. Methods: This cross-sectional study was conducted in the Neurology Department of Dr. Mohammad Hoesin General Hospital Palembang, from 1 November 2021 to 31 March 2022. Researchers used the MoCA-Ina questionnaire to collect medical record data and conduct interviews. Results: In this research, the number of research subjects obtained was 70 people with epilepsy. Characteristics of sociodemographic sufferer Epilepsy in this study was mostly (44.3%) aged 26 – 45 years with type sex most were women (71.4%), and the majority subjects (52.9%) had level high school education. Characteristics of antiepileptic drugs consumed by people living with epilepsy: most of them, i.e., amounting to 57.1%, have consumed antiepileptic drugs for > 12 months. Most of the research subjects (64.3%) had function-impaired cognitive range MoCA-Ina scores of 8 – 30. The function most cognitively disturbed, namely in the memory domain, cancels that am, counting to 82.9%. Education level is the only variable from characteristics of sociodemographic and clinical features connected significantly to cognitive function in general (p-value 0.013). The number, duration, and type of antiepileptic drugs do not determine a significant relationship with cognitive function in general. Conclusion: There is a significant relationship between valproic acid and the number of AEDs with the naming domain, as well as between valproic acid and the duration of AEDs with the abstraction domain.
- 26 June 2025
- Published by Brawijaya University in MNJ (Malang Neurology Journal)
- Vol. 11 (2) , 164-169
Open AccessTHE RELATIONSHIP OF THE CHARACTERISTICS OF ANTI-EPILEPSY DRUGS WITH THE C OGNITIVE FUNCTION OF EPILEPSY PATIENTS
Background: One of the side effects of the use of antiepileptic drugs (AEDs) is cognitive disorder. Several studies show a relationship between the type of AEDs and cognitive disturbance in people with epilepsy. Dose-dependent side effects of AEDs have also been reported in prior research. However, there are results from different studies on different populations. Objective: This research aims to evaluate the relationship between AEDs characteristics and the cognitive function of epilepsy patients. Methods: This cross-sectional study was conducted in the Neurology Department of Dr. Mohammad Hoesin General Hospital Palembang, from 1 November 2021 to 31 March 2022. Researchers used the MoCA-Ina questionnaire to collect medical record data and conduct interviews. Results: In this research, the number of research subjects obtained was 70 people with epilepsy. Characteristics of sociodemographic sufferer Epilepsy in this study was mostly (44.3%) aged 26 – 45 years with type sex most were women (71.4%), and the majority subjects (52.9%) had level high school education. Characteristics of antiepileptic drugs consumed by people living with epilepsy: most of them, i.e., amounting to 57.1%, have consumed antiepileptic drugs for > 12 months. Most of the research subjects (64.3%) had function-impaired cognitive range MoCA-Ina scores of 8 – 30. The function most cognitively disturbed, namely in the memory domain, cancels that am, counting to 82.9%. Education level is the only variable from characteristics of sociodemographic and clinical features connected significantly to cognitive function in general (p-value 0.013). The number, duration, and type of antiepileptic drugs do not determine a significant relationship with cognitive function in general. Conclusion: There is a significant relationship between valproic acid and the number of AEDs with the naming domain, as well as between valproic acid and the duration of AEDs with the abstraction domain.
- Open Access
- 30 April 2025
- Published by Universitas Negeri Semarang in Journal of Private and Commercial Law
- Vol. 8 (2) , 90-109
Unlawful Acts in Determination of Joint Property and Donations Study of Decision Number 190/Pdt.G/2018/Pn.Kpg
Analysis of Padang District Court Decision Plaintiff Name Aleta Salomi Derica Kale-Pa Number 190/Pdt.G/2018/PN.Kpg., concerning joint property grants. The legal issues raised in this analysis are: How is the analysis of the determination of joint property in Decision Number 190/Pdt.G/2018/PN.Kpg? And how can grants and control over the object of the grant be categorized as unlawful acts in Decision Number 190/Pdt.G/2018/PN.Kpg? The method used in this analysis is the IRAC Method which is a legal reasoning method with issue analysis (I), rule of law (R), argument (A), and conclusion (C). Several legal issues analyzed from the decision are to determine the object of the grant, in this case land, which is joint property, the judge's first step is to prove that the plaintiff and the landowner are husband and wife as evidenced by the Marriage Certificate. Then the next proof is related to the determination of joint property as evidenced by the land sale and purchase document. Regarding the sale and purchase process, it is also supported by the testimony of witnesses who in essence state that the witnesses know directly about the sale and purchase of the land. The grant in Decision Number 190/Pdt.G/2018/PN.Kpg has been declared as an unlawful act because the object of the grant has been proven to be joint property that was granted without the consent of the Plaintiff as the wife of the landowner. Thus, the grant is declared contrary to Article 36 paragraph 1 of Law Number 1 of 1974 concerning Marriage, Article 1666 of the Civil Code and Article 584 of the Civil Code. So based on the civil legal basis, the grant made by an unauthorized party must be declared null and void as an absolute nullity with all its legal consequences. Thus, according to the research, the decision of Decision Number 190/Pdt.G/2018/PN.Kpg is correct because the judge's considerations are in accordance with the concrete evidence as submitted by the parties.
- 30 April 2025
- Published by Universitas Negeri Semarang in Journal of Private and Commercial Law
- Vol. 8 (2) , 90-109
Open AccessUnlawful Acts in Determination of Joint Property and Donations Study of Decision Number 190/Pdt.G/2018/Pn.Kpg
Analysis of Padang District Court Decision Plaintiff Name Aleta Salomi Derica Kale-Pa Number 190/Pdt.G/2018/PN.Kpg., concerning joint property grants. The legal issues raised in this analysis are: How is the analysis of the determination of joint property in Decision Number 190/Pdt.G/2018/PN.Kpg? And how can grants and control over the object of the grant be categorized as unlawful acts in Decision Number 190/Pdt.G/2018/PN.Kpg? The method used in this analysis is the IRAC Method which is a legal reasoning method with issue analysis (I), rule of law (R), argument (A), and conclusion (C). Several legal issues analyzed from the decision are to determine the object of the grant, in this case land, which is joint property, the judge's first step is to prove that the plaintiff and the landowner are husband and wife as evidenced by the Marriage Certificate. Then the next proof is related to the determination of joint property as evidenced by the land sale and purchase document. Regarding the sale and purchase process, it is also supported by the testimony of witnesses who in essence state that the witnesses know directly about the sale and purchase of the land. The grant in Decision Number 190/Pdt.G/2018/PN.Kpg has been declared as an unlawful act because the object of the grant has been proven to be joint property that was granted without the consent of the Plaintiff as the wife of the landowner. Thus, the grant is declared contrary to Article 36 paragraph 1 of Law Number 1 of 1974 concerning Marriage, Article 1666 of the Civil Code and Article 584 of the Civil Code. So based on the civil legal basis, the grant made by an unauthorized party must be declared null and void as an absolute nullity with all its legal consequences. Thus, according to the research, the decision of Decision Number 190/Pdt.G/2018/PN.Kpg is correct because the judge's considerations are in accordance with the concrete evidence as submitted by the parties.
- Open Access
- 3 February 2025
- Published by Medical Association of Zenica-Doboj in Medicinski Glasnik
- Vol. 22 (1) , 59-64
Evaluation of risk factors for metabolic syndrome in epileptic patients in Palembang, Indonesia: a hospital-based and case-control study
Aim To examine the association between metabolic syndrome and risk factors in epileptic patients at Dr. Mohammad Hoesin General Hospital in Palembang, Indonesia.Methods A hospital-based comparative case control research was conducted from July to September 2023. A total of 102 patients in the epilepsy group and 102 in the control group participated in this study. We conducted the data collection approach in three stages: a questionnaire, anthropometric measures and biochemical analysis. Results Epilepsy patients were more likely to develop metabolic syndrome than the controls. The epilepsy group exhibited higher triglycerides, fasting blood sugar, and lower high density lipoprotein (HDL) values than the control group. The epilepsy group exhibited sedentary behaviour, while the control group had moderate to intense physical activity (p25 had 1.57 times the risk of metabolic syndrome (OR=1.57; 95%CI=1.16-2.34). Epilepsy patients with total cholesterol levels >200 mg/dL have a 5.81-fold higher risk of metabolic syndrome (OR=5.81; 95%CI=1.23-23.32). Conclusion Our study found that more than a quarter of epilepsy patients have metabolic syndrome. The main risk factors for metabolic syndrome in epilepsy patients were a sedentary lifestyle, several antiepileptic medications, overweight, and increased total cholesterol levels.
- 3 February 2025
- Published by Medical Association of Zenica-Doboj in Medicinski Glasnik
- Vol. 22 (1) , 59-64
Open AccessEvaluation of risk factors for metabolic syndrome in epileptic patients in Palembang, Indonesia: a hospital-based and case-control study
Aim To examine the association between metabolic syndrome and risk factors in epileptic patients at Dr. Mohammad Hoesin General Hospital in Palembang, Indonesia.Methods A hospital-based comparative case control research was conducted from July to September 2023. A total of 102 patients in the epilepsy group and 102 in the control group participated in this study. We conducted the data collection approach in three stages: a questionnaire, anthropometric measures and biochemical analysis. Results Epilepsy patients were more likely to develop metabolic syndrome than the controls. The epilepsy group exhibited higher triglycerides, fasting blood sugar, and lower high density lipoprotein (HDL) values than the control group. The epilepsy group exhibited sedentary behaviour, while the control group had moderate to intense physical activity (p25 had 1.57 times the risk of metabolic syndrome (OR=1.57; 95%CI=1.16-2.34). Epilepsy patients with total cholesterol levels >200 mg/dL have a 5.81-fold higher risk of metabolic syndrome (OR=5.81; 95%CI=1.23-23.32). Conclusion Our study found that more than a quarter of epilepsy patients have metabolic syndrome. The main risk factors for metabolic syndrome in epilepsy patients were a sedentary lifestyle, several antiepileptic medications, overweight, and increased total cholesterol levels.
- Open Access
- 8 August 2012
- Published by Elsevier in Procedia Chemistry
- Vol. 4, 123-130
Influence of Composite Electrolyte Membrane for Proton Exchange Membrane Fuel Cells
- 8 August 2012
- Published by Elsevier in Procedia Chemistry
- Vol. 4, 123-130
Open AccessInfluence of Composite Electrolyte Membrane for Proton Exchange Membrane Fuel Cells